NCT04585581

Brief Summary

The aim of this study is to investigate whether the combination of high intensity exercise and time restricted eating before and during pregnancy can reduce the risk of hyperglycaemia during pregnancy.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
167

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Nov 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Nov 2020Dec 2026

First Submitted

Initial submission to the registry

September 25, 2020

Completed
19 days until next milestone

First Posted

Study publicly available on registry

October 14, 2020

Completed
23 days until next milestone

Study Start

First participant enrolled

November 6, 2020

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2024

Completed
2.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

3.2 years

First QC Date

September 25, 2020

Last Update Submit

April 7, 2026

Conditions

Keywords

Diet therapyExercise therapy

Outcome Measures

Primary Outcomes (1)

  • Plasma glucose concentration

    Plasma glucose concentration after 2 h oral glucose tolerance testing (75 g glucose)

    Gestational week 28

Secondary Outcomes (44)

  • Plasma glucose concentration

    Gestational week 12

  • HbA1c

    Baseline, intervention week 8, gestational week 12 and 28

  • Total cholesterol

    Baseline, intervention week 8, gestational week 12 and 28

  • Triglycerides

    Baseline, intervention week 8, gestational week 12 and 28

  • High density lipoprotein cholesterol

    Baseline, intervention week 8, gestational week 12 and 28

  • +39 more secondary outcomes

Other Outcomes (8)

  • Infant gut microbiome

    Within one week of birth, after 6 weeks and after 6 months

  • Maternal gut microbiome

    After 6 weeks after delivery and after 6 months

  • Breastmilk composition

    After 6 weeks after delivery and after 6 months

  • +5 more other outcomes

Study Arms (2)

diet + training

EXPERIMENTAL
Behavioral: time-restricted eatingBehavioral: high intensity exerciseOther: Standard Care

controls

ACTIVE COMPARATOR
Other: Standard Care

Interventions

Participants will be asked to limit the time-window for their daily energy intake to a maximum of 10 hours.

diet + training

Participants will be encouraged to exercise with high intensity 2-3 times per week

diet + training

Standard clinical care

controlsdiet + training

Eligibility Criteria

Age18 Years - 39 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • contemplating pregnancy within the next six months
  • At least one of the following criteria: BMI ≥ 25 \< 40 kg/m2, gestational diabetes in a previous pregnancy, previous infant \> 4.5 kg, fasting plasma glucose \> 5.3 mmol/L, or Non-European ethnicity

You may not qualify if:

  • On-going pregnancy
  • Trying to conceive ≥ 6 cycles at study entry
  • Known diabetes (type 1 or 2)
  • Shift work that includes night shifts \> 2 days per week
  • Previous hyperemesis
  • Known cardiovascular diseases
  • High intensity exercise ≥ 2 hours/week the last 3 months
  • Habitual eating window ≤ 12 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Olavs Hospital

Trondheim, Norway

Location

Related Publications (2)

  • Sujan MJ, Skarstad HM, Rosvold G, Fougner SL, Follestad T, Salvesen KA, Moholdt T. Time restricted eating and exercise training before and during pregnancy for people with increased risk of gestational diabetes: single centre randomised controlled trial (BEFORE THE BEGINNING). BMJ. 2025 Sep 9;390:e083398. doi: 10.1136/bmj-2024-083398.

  • Sujan MAJ, Skarstad HMS, Rosvold G, Fougner SL, Nyrnes SA, Iversen AC, Follestad T, Salvesen KA, Moholdt T. Randomised controlled trial of preconception lifestyle intervention on maternal and offspring health in people with increased risk of gestational diabetes: study protocol for the BEFORE THE BEGINNING trial. BMJ Open. 2023 Oct 4;13(10):e073572. doi: 10.1136/bmjopen-2023-073572.

MeSH Terms

Conditions

Diabetes, Gestational

Interventions

High-Intensity Interval TrainingStandard of Care

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Øystein Risa

    Norwegian University of Science and Technology, Fac MH ISB

    STUDY DIRECTOR
  • Kjell Å Salvesen, md prof

    St Olavs Hospital, Dept Obstetrics & Gynecology

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2020

First Posted

October 14, 2020

Study Start

November 6, 2020

Primary Completion

February 5, 2024

Study Completion (Estimated)

December 1, 2026

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

We will share individual participant data that underlie the results in publications, after deidentification (text, tables, figures, and appendices).

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Immediately following publication, with no end date.
Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose, to achieve aims in the approved proposals, or for individual participant data meta-analyses. Proposals should be directed to trine.moholdt@ntnu.no. To gain access, data requestors will need to sign a data access agreement.

Locations